Cybin announces publication of international pct patent application for inhalation delivery of multiple psychedelic molecules

Toronto--(business wire)--cybin inc. (neo:cybn) (nyse american:cybn) (cybin or the company), a biopharmaceutical company focused on progressing “psychedelics to therapeutics™”, today announced that the world intellectual property organization (wipo) published an international patent application covering a range of inhalation delivery methods across multiple psychedelic molecules (patent cooperation treaty (pct) patent application no.pct/ep2021/077057), further strengthening its long-term intell
CYBN Ratings Summary
CYBN Quant Ranking